Zoetis Inc. $ZTS Shares Purchased by Landscape Capital Management L.L.C.

Landscape Capital Management L.L.C. raised its stake in Zoetis Inc. (NYSE:ZTS) by 127.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,260 shares of the company’s stock after purchasing an additional 23,121 shares during the period. Landscape Capital Management L.L.C.’s holdings in Zoetis were worth $6,037,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Halbert Hargrove Global Advisors LLC raised its holdings in Zoetis by 496.6% in the third quarter. Halbert Hargrove Global Advisors LLC now owns 173 shares of the company’s stock valued at $25,000 after acquiring an additional 144 shares in the last quarter. Financial Consulate Inc. acquired a new position in Zoetis during the 3rd quarter worth approximately $39,000. SJS Investment Consulting Inc. increased its position in shares of Zoetis by 1,606.3% in the 3rd quarter. SJS Investment Consulting Inc. now owns 273 shares of the company’s stock valued at $40,000 after purchasing an additional 257 shares during the last quarter. TruNorth Capital Management LLC purchased a new stake in shares of Zoetis in the 3rd quarter valued at approximately $42,000. Finally, Financial Gravity Companies Inc. acquired a new stake in shares of Zoetis in the 2nd quarter valued at $47,000. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on ZTS shares. Stifel Nicolaus lowered their target price on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating for the company in a research note on Tuesday, November 18th. BTIG Research reaffirmed a “buy” rating and set a $160.00 price objective on shares of Zoetis in a research report on Thursday, February 26th. Piper Sandler reissued a “neutral” rating and set a $135.00 target price (down from $190.00) on shares of Zoetis in a research report on Thursday, January 22nd. Wall Street Zen upgraded Zoetis from a “hold” rating to a “buy” rating in a research note on Saturday, February 21st. Finally, Barclays began coverage on Zoetis in a report on Monday, December 8th. They issued an “equal weight” rating and a $136.00 price target for the company. Six investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $152.91.

Zoetis Stock Performance

NYSE ZTS traded up $0.56 during trading hours on Friday, hitting $116.02. The company had a trading volume of 299,385 shares, compared to its average volume of 4,413,535. The business has a 50 day moving average of $125.54 and a 200-day moving average of $132.19. The company has a market cap of $48.97 billion, a PE ratio of 19.25, a price-to-earnings-growth ratio of 1.83 and a beta of 0.95. Zoetis Inc. has a 1-year low of $115.23 and a 1-year high of $172.23. The company has a debt-to-equity ratio of 2.71, a quick ratio of 1.94 and a current ratio of 3.03.

Zoetis (NYSE:ZTS) last posted its earnings results on Thursday, February 12th. The company reported $1.48 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.08. The business had revenue of $2.39 billion for the quarter, compared to analysts’ expectations of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The business’s revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.40 earnings per share. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. As a group, equities research analysts expect that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be issued a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis’s dividend payout ratio is presently 35.22%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.